After 37 Years, Rabbi Baruch and Rivka Wilhelm, who both struggled with hearing impairments for most of their lives, finally ...
Recent clinical trial update news from Aethlon Medical, Inc. ( Nasdaq: AEMD ), Envoy Medical, Inc. ( Nasdaq: COCH ), ...
You can get FluMist for self-administration (called FluMist Home) by visiting the manufacturer’s website. You’ll need to ...
Recent clinical trial update news from Aethlon Medical, Inc. (NASDAQ: AEMD), Envoy Medical, Inc. (NASDAQ: COCH), Soligenix, ...
A special toy is helping young patients at Ottawa's children's hospital understand their medical journey, and it was all ...
The Australian life sciences sector has the right science, capability and capital to succeed – but that has not always been ...
Envoy Medical secured FDA approval to expand its Acclaim cochlear implant trial, accelerating timelines and reducing capital ...
A local man just got a new cochlear implant that runs its own firmware, similar to an iPhone. It’s helped him to hear his ...
Most patients with Meniere disease (MD) who undergo cochlear implantation (CI) in the MD-affected ear have stability or ...
InvestorsHub on MSN
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial
Envoy Medical Inc. (NASDAQ:COCH) saw its shares soar 150% in premarket trading on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) had granted approval to expand ...
Southwell ear, nose and throat specialist and head and neck surgeon Dontre’ Douse, M.D. recently performed the first cochlear ...
Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback